BioMedNewsBreaks – Gaxos.ai Inc. (NASDAQ: GXAI) Advances Anti-Drone Capabilities Through AFD Deployment Of Anduril Lattice Platform

Gaxos.ai (NASDAQ: GXAI) announced that its portfolio company, America First Defense (AFD), has begun deployment of the Anduril Lattice Platform to expand its counter-swarm UAV and anti-drone defense systems, marking a key milestone in advancing its autonomous defense infrastructure. The integration enhances AFD’s ability to identify, track, assess and respond to evolving unmanned aerial threats, supporting its focus on layered, AI-enabled counter-UAS solutions as demand grows for adaptive, software-defined defense technologies.

To view the full press release, visit https://ibn.fm/KoGYn

About Gaxos.ai Inc.

Gaxos.AI is a technology company focused on reshaping the way people interact with artificial intelligence across everyday life and high-impact industries. More than a developer of applications, Gaxos.AI is building a portfolio of AI-powered solutions designed to make advanced technology more practical, accessible, and transformative. The company’s growing portfolio spans defense, health and wellness, entertainment, and productivity—bringing intelligent tools to markets where innovation can drive meaningful real-world outcomes.

NOTE TO INVESTORS: The latest news and updates relating to GXAI are available in the company’s newsroom at https://ibn.fm/GXAI

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
Editor@BioMedWire.com

BioMedWire is powered by IBN